SCHEMBL2472822

SCHEMBL2472822

CC1CC(Cl)(c2ccc3c(c2)CNCc2nncn2-3)CCC1Oc1ccncn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2471774 0.90 CYP11B2 (0.30)
SCHEMBL2471322 0.90 AVPR1A (0.33)
SCHEMBL2474676 0.89 AVPR1A (0.31)
SCHEMBL2474258 0.88
Hydrochloric Acid SCHEMBL2472336 0.87
SCHEMBL2475001 0.85 AADAT (0.32)
SCHEMBL2474345 0.85
SCHEMBL2340647 0.83
SCHEMBL2565568 0.80 AVPR1A (0.31)
SCHEMBL2564790 0.79 CYP11B2 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2370441-A1 ARYLCYCLOHEXYLETHERS OF DIHYDROTETRAAZABENZOAZULENES FOR USE AS VASOPRESSIN VIA RECEPTOR ANTAGONISTS F. Hoffmann-La Roche AG (CH) 2011-10-05 EP disclosed
WO-2010060836-A1 ARYLCYCLOHEXYLETHERS OF DIHYDROTETRAAZABENZOAZULENES FOR USE AS VASOPRESSIN VIA RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2010-06-03 WO disclosed